VIIV HEALTHCARE TRADING SERVICES UK LIMITED
Get an alert when VIIV HEALTHCARE TRADING SERVICES UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.3M
+8.7% vs 2023
Net assets
£12M
-68.1% vs 2023
Employees
6
-14.3% vs 2023
Profit before tax
£14M
+0.9% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £5,081,913,000 | £6,066,766,000 | +19.4% | |
| Operating profit | £21,057,000 | £7,105,000 | -66.3% | |
| Profit before tax | £13,804,000 | £13,928,000 | +0.9% | |
| Net profit | £11,259,000 | £11,185,000 | -0.7% | |
| Cash | £1,178,000 | £1,280,000 | +8.7% | |
| Total assets less current liabilities | £37,966,000 | £12,119,000 | -68.1% | |
| Net assets | £37,966,000 | £12,119,000 | -68.1% | |
| Equity | £37,966,000 | £12,119,000 | -68.1% | |
| Average employees | 7 | 6 | -14.3% | |
| Wages | £1,874,000 | £1,682,000 | -10.2% | |
| Directors' remuneration | £0 | £0 | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 0.4% | 0.1% | |
| Net margin | 0.2% | 0.2% | |
| Return on capital employed | 55.5% | 58.6% | |
| Gearing (liabilities / total assets) | 94.2% | 96.7% | |
| Current ratio | 1.06x | 1.03x | |
| Interest cover | 2.90x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. The Directors in their considerations have included operational risks to holding and transporting inventory. The Directors, have considered the Company's ability to continue as a going concern for a minimum of twelve months from the date of signing of these financial statements. The Directors have taken into account that, as part of the Group, the Company has the support from the Group through the access to the Group cash pooling mechanism and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “On 28 June 2024, the Company declared an interim dividend of £37,000,000 to its parent company, ViiV Healthcare Limited which was paid on 30 July 2024.”
- “The Company is assessing the impact of adopting the new requirements introduced by IFRS 18, and will adopt the standard for the reporting period ending 31 December 2027, subject to endorsement in the UK.”
- “The Company, together with fellow Group undertakings, has entered into a Group banking arrangement with the Company's principal bank.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2021-03-25 | — | — |
| VIIV HEALTHCARE UK LIMITED | Corporate Secretary | 2009-10-30 | — | — |
| HALL, Rebecca Elizabeth | Director | 2024-11-01 | Feb 1982 | British |
| LAWTON, Shenaz | Director | 2024-11-01 | Nov 1976 | British |
| LYNCH, Aidan | Director | 2019-10-01 | Feb 1964 | Irish |
| SALTON, Neale Andrew | Director | 2024-11-01 | Jan 1963 | English |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CRANDALL, Terry Lynn | Secretary | 2009-10-30 | 2013-10-10 |
| HILLIER, Laura Kate | Secretary | 2013-10-10 | 2017-10-06 |
| WHYTE, Victoria Anne | Secretary | 2009-08-05 | 2009-10-30 |
| ANDERSON, Jill Dawn | Director | 2018-09-01 | 2023-03-01 |
| ANDRIES, Jerome Charles Maurice | Director | 2013-08-01 | 2017-09-30 |
| DAWSON, Mark Robert | Director | 2015-07-01 | 2017-05-31 |
| GRAINGER, Karen Marion | Director | 2017-06-01 | 2024-11-01 |
| LIMET, Dominique Jean Marc | Director | 2009-09-11 | 2017-03-31 |
| MACDIARMID, Cheryl Faye | Director | 2019-05-03 | 2024-04-01 |
| REINAUD, Gregory Maxime | Director | 2017-03-31 | 2019-02-04 |
| SHORTMAN, Neil Peter | Director | 2015-07-01 | 2017-06-07 |
| WATERHOUSE, Deborah Jayne | Director | 2017-09-22 | 2024-11-01 |
| WHYTE, Victoria Anne | Director | 2009-08-05 | 2009-10-30 |
| WILKINSON, Neil Richard | Director | 2023-03-01 | 2024-11-01 |
| WILLIAMS, Subesh Ronald | Director | 2009-09-11 | 2013-08-01 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2009-08-05 | 2009-10-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Viiv Healthcare Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 82 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-04 | CH04 | officers | Change corporate secretary company with change date | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2024-11-11 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-04 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-23 | CH01 | officers | Change person director company with change date | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | CH04 | officers | Change corporate secretary company with change date | |
| 2024-09-11 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-07-18 | AD02 | address | Change sail address company with new address | |
| 2024-07-16 | AA | accounts | Accounts with accounts type full | |
| 2024-04-11 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-25 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.